SCHEMBL5264174

SCHEMBL5264174

OCCc1ccc(OBOc2ccc(CCO)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.52
TDP1 Q9NUW8 1/20 0.48
PPARA Q07869 2/20 0.47
CYP4F2 P78329 4/20 0.44
CYP4A11 Q02928 4/20 0.44
HRH3 Q9Y5N1 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
TSHR P16473 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
ALOX5 P09917 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3321418 0.89 LTA4H (0.53) CA2TDP1PPARACYP4F2CYP4A11
SCHEMBL19342361 0.84 CA2 (0.50) CA2TDP1PPARACYP4F2CYP4A11
SCHEMBL111192 0.83 LTA4H (0.52) CA2PPARACYP4F2CYP4A11HRH3
SCHEMBL2167811 0.80 CA2 (0.56) CA2TDP1PPARACYP4F2CYP4A11
SCHEMBL3289628 0.79 THRB (0.47) CA2PPARAALDH1A1
SCHEMBL9145079 0.79 TDP1 (0.46) CA2TDP1PPARAHRH3CALM1
SCHEMBL6869832 0.79 MAOA (0.48) TDP1PPARALTA4HEPHX2
SCHEMBL4715391 0.79 TAAR1 (0.59) KDM4EALDH1A1BACE1
SCHEMBL40656 0.79 CA2 (0.77) CA2TDP1PPARACYP4F2CYP4A11
SCHEMBL5798172 0.77 FFAR1 (0.62)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740551-A1 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF AS AN MMP-13 INHIBITOR Takeda Pharmaceutical Company Limited (JP) 2007-01-10 EP disclosed
WO-2005105760-A1 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF AS AN MMP-13 INHIBITOR TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-11-10 WO disclosed
US-5387409-A Diagnostic imaging agents, e.g. hypoxic tissue; radiotherapy; kits BRACCO INTERNATIONAL B.V. (NL) 1995-02-07 US disclosed
EP-0441491-A1 Boronic acid adducts of rhenium dioxime and technetium-99M dioxime complexes containing a biochemically active group BRACCO INTERNATIONAL B.V. (NL) 1991-08-14 EP disclosed